APA aipamena

Filimoniuk, A., Blachnio-Zabielska, A., Imierska, M., Lebensztejn, D. M., & Daniluk, U. (2020). Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Biomolecules.

Chicago Style aipamena

Filimoniuk, Aleksandra, Agnieszka Blachnio-Zabielska, Monika Imierska, Dariusz Marek Lebensztejn, and Urszula Daniluk. "Sphingolipid Analysis Indicate Lactosylceramide As a Potential Biomarker of Inflammatory Bowel Disease in Children." Biomolecules 2020.

MLA aipamena

Filimoniuk, Aleksandra, et al. "Sphingolipid Analysis Indicate Lactosylceramide As a Potential Biomarker of Inflammatory Bowel Disease in Children." Biomolecules 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.